Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Date of authorisation: 15/07/1998, Revision: 53, Status: Authorised

PSUSA/00000699/202411

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 13, Status: Authorised

PSUSA/00009247/202411

PSUSA/00001021/202411

IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants

Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 14, Status: Authorised

PSUSA/00009326/202411